Polyrizon (PLRZ) Competitors $1.04 +0.36 (+52.47%) As of 07/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PLRZ vs. HOOK, ATHA, EDSA, SONN, ERNA, BFRG, SYBX, IBIO, FLGC, and TXMDShould you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include HOOKIPA Pharma (HOOK), Athira Pharma (ATHA), Edesa Biotech (EDSA), Sonnet BioTherapeutics (SONN), Ernexa Therapeutics (ERNA), Bullfrog AI (BFRG), Synlogic (SYBX), iBio (IBIO), Flora Growth (FLGC), and TherapeuticsMD (TXMD). These companies are all part of the "pharmaceutical products" industry. Polyrizon vs. Its Competitors HOOKIPA Pharma Athira Pharma Edesa Biotech Sonnet BioTherapeutics Ernexa Therapeutics Bullfrog AI Synlogic iBio Flora Growth TherapeuticsMD HOOKIPA Pharma (NASDAQ:HOOK) and Polyrizon (NASDAQ:PLRZ) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment. Do analysts rate HOOK or PLRZ? HOOKIPA Pharma presently has a consensus price target of $4.50, indicating a potential upside of 284.62%. Given HOOKIPA Pharma's stronger consensus rating and higher probable upside, analysts plainly believe HOOKIPA Pharma is more favorable than Polyrizon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HOOKIPA Pharma 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Polyrizon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HOOK or PLRZ more profitable? Polyrizon has a net margin of 0.00% compared to HOOKIPA Pharma's net margin of -785.66%. Polyrizon's return on equity of 0.00% beat HOOKIPA Pharma's return on equity.Company Net Margins Return on Equity Return on Assets HOOKIPA Pharma-785.66% -120.09% -77.14% Polyrizon N/A N/A N/A Do insiders and institutionals have more ownership in HOOK or PLRZ? 63.9% of HOOKIPA Pharma shares are owned by institutional investors. 3.3% of HOOKIPA Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings and valuation, HOOK or PLRZ? Polyrizon has lower revenue, but higher earnings than HOOKIPA Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHOOKIPA Pharma$43.95M0.32-$43.50M-$5.85-0.20PolyrizonN/AN/A-$1.54MN/AN/A Does the media prefer HOOK or PLRZ? In the previous week, Polyrizon had 4 more articles in the media than HOOKIPA Pharma. MarketBeat recorded 5 mentions for Polyrizon and 1 mentions for HOOKIPA Pharma. HOOKIPA Pharma's average media sentiment score of 1.89 beat Polyrizon's score of 0.63 indicating that HOOKIPA Pharma is being referred to more favorably in the media. Company Overall Sentiment HOOKIPA Pharma Very Positive Polyrizon Positive SummaryHOOKIPA Pharma beats Polyrizon on 7 of the 12 factors compared between the two stocks. Get Polyrizon News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRZ vs. The Competition Export to ExcelMetricPolyrizonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.63M$2.96B$5.61B$9.29BDividend YieldN/A2.43%4.23%4.03%P/E RatioN/A20.2228.5419.58Price / SalesN/A299.17429.2495.01Price / CashN/A43.1536.0257.93Price / Book0.007.568.145.54Net Income-$1.54M-$55.11M$3.24B$257.73M7 Day Performance45.80%3.81%0.18%-0.08%1 Month Performance29.64%11.60%5.96%8.09%1 Year PerformanceN/A-2.11%26.24%13.02% Polyrizon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRZPolyrizonN/A$1.04+52.5%N/AN/A$3.63MN/A0.00N/ANews CoverageHigh Trading VolumeHOOKHOOKIPA Pharma3.0496 of 5 stars$1.21flat$4.50+271.9%-80.2%$14.75M$9.35M-0.21160Positive NewsATHAAthira Pharma3.4451 of 5 stars$0.40+9.3%$11.25+2,681.2%-88.2%$14.45MN/A-0.2040Positive NewsEDSAEdesa Biotech2.2459 of 5 stars$2.11+2.9%$5.00+137.0%-48.5%$14.40MN/A-1.3320Positive NewsSONNSonnet BioTherapeutics3.7511 of 5 stars$4.64+3.8%$20.00+331.0%+38.4%$14.15M$1M0.0010Trending NewsGap DownERNAErnexa Therapeutics0.5727 of 5 stars$1.95+1.6%N/A-93.9%$14.14M$580K-0.2310BFRGBullfrog AI0.4541 of 5 stars$1.49-0.7%N/A-45.6%$14.12M$60K-1.844SYBXSynlogic1.1535 of 5 stars$1.24+4.2%N/A-14.3%$13.92M$10K-0.4980Positive NewsIBIOiBio1.2706 of 5 stars$0.840.0%$4.30+414.7%-68.4%$13.81M$375K0.00100FLGCFlora Growth2.618 of 5 stars$0.64+4.1%$4.00+529.9%-39.9%$13.77M$59.51M-0.65280Positive NewsTXMDTherapeuticsMD0.4284 of 5 stars$1.22+3.4%N/A-37.3%$13.66M$1.76M0.00420 Related Companies and Tools Related Companies HOOKIPA Pharma Alternatives Athira Pharma Alternatives Edesa Biotech Alternatives Sonnet BioTherapeutics Alternatives Ernexa Therapeutics Alternatives Bullfrog AI Alternatives Synlogic Alternatives iBio Alternatives Flora Growth Alternatives TherapeuticsMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRZ) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLRZ Stock Alerts